Parallel Advisors’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-796
| Closed | -$3.25K | – | 3557 |
|
|
2023
Q1 | $3.25K | Buy |
796
+753
| +1,751% | +$3.07K | ﹤0.01% | 2575 |
|
|
2022
Q4 | $216 | Buy |
43
+18
| +72% | +$90 | ﹤0.01% | 3177 |
|
|
2022
Q3 | $0 | Sell |
25
-23
| -48% | – | ﹤0.01% | 3591 |
|
|
2022
Q2 | $1K | Buy |
+48
| New | +$1K | ﹤0.01% | 2892 |
|
|
2022
Q1 | – | Sell |
-112
| Closed | -$2K | – | 3360 |
|
|
2021
Q4 | $2K | Sell |
112
-90
| -45% | -$1.61K | ﹤0.01% | 2774 |
|
|
2021
Q3 | $4K | Buy |
+202
| New | +$4K | ﹤0.01% | 2499 |
|